17 February 2020

Esperite update the market

Esperite NV (Esperite, The Company) updates its shareholders on the current configuration and business of the company.

The company has taken distance from the operative part of its activities and focus its effort on turning itself in an investment company with a focus on Health Care and High-Tech Service.

***

read more

ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020

Amsterdam, The Netherlands – 13 February 2020

***

PDF Downloads – EGM 26 March 2020

           Press Release :  EGM-26-March-2020-Press-Release-1.pdf

          Agenda  :              EGM-26-March-2020-Agenda-1.pdf

          Notice  :                EGM-26-March-2020-Notice-1.pdf

Explanatory Notes :   EGM-26-March-2020-Explanatory-Notes-1.pdf

Power of Attorney :    EGM-26-March-2020-Power-of-Attorney-1.pdf

read more

ESPERITE N.V: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.

Amsterdam, The Netherlands – 10 February 2020

***

read more

ESPERITE (ESP) is not bankrupt.  

Amsterdam, The Netherlands – 30 October 2019

***

 This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

read more

ESPERITE (ESP) disputes the Court verdict and appeals the order.

Amsterdam, The Netherlands – 14 October 2019

To learn more about the ESPERITE Group, info@esperitegroup.com or visit the website at www.esperite.com,

***

 This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

read more

Esperite N.V. (ESP): Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.

Amsterdam, The Netherlands – 30 September 2019 read more

CryoSave has maintained without compromise the highquality processing and storage services and has handed over its whole business.

Switzerland – 19 September 2019
read more

ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS

Amsterdam, The Netherlands – 27 August 2019
read more

ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report

Amsterdam, The Netherlands – 3 July 2019
read more

ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.

Amsterdam, The Netherlands – 2nd July 2019
read more